A New Vista of Aldehyde Dehydrogenase 1A3 (ALDH1A3): New Specific Inhibitors and Activity-Based Probes Targeting ALDH1A3 Dependent Pathways in Glioblastoma, Mesothelioma and Other Cancers.

L Magrassi, GIULIA PINTON, S Luzzi, S Comincini, A Scravaglieri, V Gigliotti, Bernardoni BL, I D'Agostino, F Juretich, Motta C La, Silvia GARAVAGLIA

Risultato della ricerca: Contributo su rivistaArticolo in rivistapeer review

Abstract

Aldehyde dehydrogenases of the subfamily 1A (ALDH1A) are enzymes involved in the synthesis of retinoic acid, which is necessary for the normal development and maintenance of epithelia, reproduction, memory, and immune function in adults. ALDH1A3, one of the enzymes that belong to the ALD1A subfamily, is also expressed at high levels in many human cancers like glioblastoma and mesothelioma. Herein, we review the role of ALDH1A3 in cancer, showing its relation with excessive proliferation, chemoresistance, and invasiveness. We also illustrate the current attempts to develop ALDH1A3-selective inhibitors and specific fluorescent probes that are potentially useful for cancer therapy and fluorescence-guided tumor resection.
Lingua originaleInglese
RivistaCancers
DOI
Stato di pubblicazionePubblicato - 2024

Keywords

  • ALDH1A3
  • aldehyde dehydrogenase
  • cancers
  • fluorescence-guided surgery
  • glioblastoma
  • mesothelioma
  • retinoic acid

Fingerprint

Entra nei temi di ricerca di 'A New Vista of Aldehyde Dehydrogenase 1A3 (ALDH1A3): New Specific Inhibitors and Activity-Based Probes Targeting ALDH1A3 Dependent Pathways in Glioblastoma, Mesothelioma and Other Cancers.'. Insieme formano una fingerprint unica.

Cita questo